<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bao L</submitter><funding>National Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>200</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8134832</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(1)</volume><pubmed_abstract>Influenza A virus may circulate simultaneously with the SARS-CoV-2 virus, leading to more serious respiratory diseases during this winter. However, the influence of these viruses on disease outcome when both influenza A and SARS-CoV-2 are present in the host remains unclear. Using a mammalian model, sequential infection was performed in ferrets and in K18-hACE2 mice, with SARS-CoV-2 infection following H1N1. We found that co-infection with H1N1 and SARS-CoV-2 extended the duration of clinical manifestation of COVID-19, and enhanced pulmonary damage, but reduced viral shedding of throat swabs and viral loads in the lungs of ferrets. Moreover, mortality was increased in sequentially infected mice compared with single-infection mice. Compared with single-vaccine inoculation, co-inoculation of</pubmed_abstract><journal>Signal transduction and targeted therapy</journal><pubmed_title>Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.</pubmed_title><pmcid>PMC8134832</pmcid><funding_grant_id>82041035</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Gong S</pubmed_authors><pubmed_authors>Cong B</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Zhao B</pubmed_authors><pubmed_authors>Yu P</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Gao H</pubmed_authors><pubmed_authors>Bao L</pubmed_authors><pubmed_authors>Wei Q</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Qi F</pubmed_authors><pubmed_authors>Qu Y</pubmed_authors><pubmed_authors>Xue J</pubmed_authors><pubmed_authors>Deng W</pubmed_authors><pubmed_authors>Song Z</pubmed_authors><pubmed_authors>Lv Q</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors><pubmed_authors>Qin C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.</name><description>Influenza A virus may circulate simultaneously with the SARS-CoV-2 virus, leading to more serious respiratory diseases during this winter. However, the influence of these viruses on disease outcome when both influenza A and SARS-CoV-2 are present in the host remains unclear. Using a mammalian model, sequential infection was performed in ferrets and in K18-hACE2 mice, with SARS-CoV-2 infection following H1N1. We found that co-infection with H1N1 and SARS-CoV-2 extended the duration of clinical manifestation of COVID-19, and enhanced pulmonary damage, but reduced viral shedding of throat swabs and viral loads in the lungs of ferrets. Moreover, mortality was increased in sequentially infected mice compared with single-infection mice. Compared with single-vaccine inoculation, co-inoculation of</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-05T10:29:03.594Z</modification><creation>2022-02-10T13:59:53.717Z</creation></dates><accession>S-EPMC8134832</accession><cross_references><pubmed>34016949</pubmed><doi>10.1038/s41392-021-00618-z</doi></cross_references></HashMap>